MK2 inhibitor PF-3644022 shows protective effect in mouse microglial N9 cell line induced with cigarette smoke

Shikha Asthana1, Shivam Kumar Pandey1, Avtar Singh Gautam1

  • 1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Transit campus, Lucknow, Uttar Pradesh, India.

PubMed

Insights

Cigarette smoke (CS) triggers brain inflammation and cognitive decline by activating microglia. An MK2 inhibitor, PF-3644022, reduced CS-induced inflammation and oxidative stress in microglia.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Cigarette smoke (CS) is a significant cause of neuroinflammation, leading to cognitive impairment and neurodegeneration.
  • Microglia, the brain's resident immune cells, respond to stress via TLR4, with CS constituents promoting inflammation and oxidative stress through the TLR4-MK2 pathway.
  • The precise role of MK2 kinase in CS-induced microglial inflammation remains unclear.

Purpose of the Study:

  • To investigate the role of MK2 kinase in CS-induced microglial inflammation and oxidative stress.
  • To evaluate the effects of an MK2 inhibitor (PF-3644022) on CS-induced signaling pathways in microglia.
  • To assess the impact of direct CS exposure on acetylcholinesterase (AChE) activity.

Main Methods:

  • Utilized a mouse microglial cell line exposed to cigarette smoke extract (CSE).
  • Administered the MK2 inhibitor PF-3644022 to pretreated cells.
  • Assessed cytotoxicity, oxidative stress markers, proinflammatory cytokine release, antioxidant protein levels, and AChE enzymatic activity.

Main Results:

  • CS exposure induced microglial cytotoxicity, increased oxidative stress, and elevated proinflammatory cytokine release.
  • Pretreatment with PF-3644022 significantly attenuated CS-induced oxidative stress and inflammation markers.
  • PF-3644022 treatment improved the levels of antioxidant proteins in microglia exposed to CS.
  • Direct CS exposure reduced the enzymatic activity of acetylcholinesterase (AChE).

Conclusions:

  • MK2 kinase plays a critical role in mediating CS-induced neuroinflammation and oxidative stress in microglia.
  • Inhibiting MK2 kinase offers a potential therapeutic strategy to mitigate CS-induced neurotoxicity.
  • CS exposure directly impairs AChE activity, suggesting a link to cognitive dysfunction.

Related Concept Videos